US20050203595A1 - Ischemia laser treatment - Google Patents
Ischemia laser treatment Download PDFInfo
- Publication number
- US20050203595A1 US20050203595A1 US11/127,003 US12700305A US2005203595A1 US 20050203595 A1 US20050203595 A1 US 20050203595A1 US 12700305 A US12700305 A US 12700305A US 2005203595 A1 US2005203595 A1 US 2005203595A1
- Authority
- US
- United States
- Prior art keywords
- laser
- skull
- cranium
- brain
- irradiation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0645—Applicators worn by the patient
- A61N2005/0647—Applicators worn by the patient the applicator adapted to be worn on the head
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/067—Radiation therapy using light using laser light
Definitions
- Mammalian CNS neurons have a negligible capacity to regenerate following lesion or acute ischemic (no oxygen supply) conditions.
- a dramatic decrease or complete abolishment of oxygen supply to the nerve cells and other cells in a certain region of the brain can occur due to occlusion of one or more of the arteries that supply blood to the brain (Fisher, M., “Characterizing the Target of Acute Stroke Therapy,” Stroke , Vol. 28, No. 4, pp. 866-872, April 1997).
- the neurons of the brain go through a gradual degeneration process that eventually leads to necrosis in the acute ischemic zone.
- Clinical syndromes such as paraplegia, quadriplegia, etc., are evident due to dysfunction of the nerve cells in the brain.
- the mammalian CNS also has a negligible capacity to regenerate following injury. Limited regeneration of peripheral axons in mammals and CNS in lower vertebrate can take place in a post trauma setting.
- Low energy laser irradiation has recently been found to modulate various processes in different biological systems (Belkin, et al., a critical review of low energy laser bioeffects, Lasers Light Ophthalmology , Vol. 2, p. 63-71, 1988, and Conlan, et al., biostimulation of wound healing by low energy laser irradiation, Journal of Clinical Periodontology , Vol. 23, p. 492-496, 1996).
- the effect of low energy laser irradiation following trauma has been investigated so far in skin, peripheral nerves and skeletal muscles.
- U.S. Pat. No. 5,580,555 to Schwartz involves the administration of tumor necrosis factor (TNF) to the sight of injury in the optic nerve in order to facilitate regeneration of axons across the sight of the injury.
- TNF tumor necrosis factor
- the use of low energy laser in conjunction with the use of the TNF is suggested to augment the effect of TNF.
- Schwartz presents no experimental results to favor the beneficial effect of the laser. Furthermore, it is described in the detailed description that treatment with TNF alone (without laser irradiation) gives good results.
- U.S. Pat. No. 4,966,144 to Rochkind, et al. deals with a method of inducing functional regeneration. of nerve fibers of an injured sight. of the. spinal cord (or using grafts of peripheral nerves which were placed into the injured sight) by a light source which generates light at a wavelength of 330-1200 nm.
- the method involves only the spinal cord but not the brain.
- the method is not related to an acute ischemic phase of nerve cells in the CNS as in a situation of “stroke” nor is the cytoprotective effect of laser irradiation cited in Rochkind , et al.
- LEL irradiation allows cells under stressful conditions of low or no oxygen supply to maintain their viability in spite of the harsh conditions.
- the irradiated cells most probably do not degenerate to the same extent as the non-irradiated cells and therefore also the inflammatory response, which is typical to tissues undergoing a degenerative process following injury, is markedly decreased.
- LEL irradiation has been found to enhance the process of formation of new blood vessels (angiogenesis) in injured skeletal muscles (Bibikovu A. Belkin A. and Oron U. Enhancement of angiogenesis in regenerating gastrocnemius muscle of the toad ( Butfo Viridis ) by low energy laser irradiation. Anat. Embryol (1994), Vol. 190, pp. 597-602.).
- the present invention seeks to provide a novel method and apparatus for using LEL irradiation to protect cells under acute ischemic conditions in the brain.
- the LEL irradiation in the initial phase of ischemia, causes an enhanced angiogenesis process which in turn causes a regeneration process in the injured brain cells in the ischemic zone, thereby allowing for greater protection of the cells in the future.
- apparatus for treatment of an. ischemic region of brain cells in a cranium including a skull covering adapted to cover at least part of a cranium, at least one guide attached to the skull covering, and a laser source which is operative to direct a laser beam through the at least one guide into a cranium.
- the at least one guide may include an optic fiber or a waveguide.
- the laser source includes a diode laser.
- a laser controller is operatively connected to the laser source which controls operation of the laser source.
- an actuator which is operative to move the laser source further from or closer to a cranium.
- the skull covering includes sealing material at a skull-contacting periphery thereof.
- a timer is mounted on the skull covering.
- an indicator light is mounted on the skull covering.
- a plurality of the guides are attached to the skull covering which direct a plurality of the laser beams in a plurality of directions.
- a-plurality of the guides are attached to the skull covering which are operative to focus a plurality of the laser beams in a plurality of focal lengths into a cranium.
- a plurality of the guides is commonly attached to the laser source.
- each source directs a laser beam through one the guide.
- FIG. 1 is a simplified pictorial illustration of apparatus for treatment of an ischemic region of brain cells in a cranium, constructed and operative in accordance with a preferred embodiment of the present invention
- FIG. 2 is a simplified pictorial illustration of apparatus for treatment of an ischemic region of brain cells in a cranium, constructed and operative in accordance with another preferred embodiment of the present invention.
- FIG. 3 is a simplified pictorial illustration of apparatus for treatment of an ischemic region of brain cells in a cranium, constructed and operative in accordance with yet another preferred embodiment of the present invention.
- FIG. 1 illustrates apparatus 10 for treatment of an ischemic region of brain cells in a cranium, in accordance with a preferred embodiment of the present invention.
- Apparatus 10 preferably includes a multiplicity of laser sources 12 , such as diode lasers, arranged for multidirectional multifocal irradiation of the cranium.
- Laser sources 12 are mounted in a skull covering 14 , preferably constructed of metal, plastic or any other irradiation blocking material, and are preferably controlled by a laser controller 15 , either mounted externally or internally on skull covering 14 .
- Each laser source 12 preferably delivers laser energy to the skull via a guide 16 , such as an optic fiber or waveguide.
- Laser sources 12 are preferably connected to a servo system 18 which includes one or more actuators 20 which can move laser sources further from or closer to the cranium, thereby controlling the distance of the distal ends of guides 16 from the cranium.
- Skull covering 14 may cover the entire skull including the brainstem, or alternatively, only part of the skull.
- Apparatus 10 preferably includes one or more indicator lights 22 which provide various operational visual signals, such as malfunction warning signals, for example.
- Skull covering 14 preferably has sealing material 24 at its skull-contacting periphery so as to prevent stray radiation from escaping.
- Apparatus 10 preferably includes a timer 26 with an LCD to allow an operator to monitor the irradiation process in real time. Other safety options may be included.
- FIG. 2 illustrates apparatus 30 for treatment of an ischemic region of brain cells in a cranium, in accordance with another preferred embodiment of the present invention.
- Apparatus 30 is basically the same as apparatus 10 , with like numerals designating like elements, although not all elements are shown in FIG. 2 for the sake of simplicity.
- Apparatus 30 differs from apparatus 10 in that apparatus 30 includes one laser source 12 and a multiplicity of guides 16 which are arranged for multidirectional multifocal irradiation of the cranium, as described above for apparatus 10 .
- FIG. 3 illustrates apparatus 40 for treatment of an ischemic region of brain cells in a cranium, in accordance with yet another preferred embodiment of the present invention.
- Apparatus 40 is basically the same as apparatus 10 or 30 , with like numerals designating like elements, although not all elements are shown in FIG. 3 for the sake of simplicity.
- Apparatus 40 differs from apparatus 10 or 30 in that apparatus 40 also includes a heartbeat sensor probe 42 .
- Guide 16 may be housed inside or outside of probe 42 , in accordance with the requirements of the particular application.
- Apparatus 40 is particularly useful for treating newborn infants, as is now described.
- a newborn may be subject to different kinds of stress-elated problems, one example being insufficient oxygen and blood supply to the brain which is a major cause of morbidity and mortality.
- Factors contributing to brain damage and other adverse outcomes are complex. Both severe hypoxia-ischemia and prolonged hypoxia of lesser severity may cause brain damage (Low J A, Cerebral perfusion, metabolism and outcome; Curr Opin Pediatr: 7(2): pp. 132-9 April 1995).
- hypoxia such as hypoxic-ischemic encephalopathy., cerebral palsy, microcephaly, seizure disorders, mental retardation, educational failure and others (Behrman, Kliegman, et al., Nelson's Textbook of Pediatrics, 15th Ed. W. B. Saunders Company: pp. 431-3; 1996).
- Apparatus 40 is particularly useful for treating newborns, such as during exit from the vagina, wherein laser sources 12 can deliver laser energy to the: cranium of the newborn infant quickly and efficiently.
- apparatus 40 may be fashioned without skull covering 14 , if desired.
- skull coverings 14 of different sizes and shapes may be provided to a hospital or clinic for perinatal care.
- Different energy delivery coefficients may be calculated for laser sources 12 depending upon the particular application. The position of the laser sources and the paths of the laser beams into the cranium are based on various factors, such as an anatomical consideration of the newborn (for example, the anatomy of the fontanels).
- Apparatus 40 can be combined with conventional monitoring systems and with those under current development.
- the technique of irradiating the brain with apparatus 40 may be used in conjunction with other methods for protecting the brain, such as the use of glutamate receptor antagonists, glucocorticoids, voltage sensitive calcium channel antagonists etc. (Tuor U I, Del Bigio . M R et al., Brain damage due to cerebral hypoxialischemia in. the neonate: pathology and pharmacological modification; Cerebrovasc Brain Metab Rev, 8(2): pp 159-93 Summer 1996).
- the left common carotid artery of 12 mature Sprague-Dawley rats (250-300 gr. body weight anesthetized with Avertin) was exposed by a longitudinal incision to the frontal midline section of the neck. It was then occluded by ligation with a silk (4-0) thread.
- the brains of six rats were irradiated by a diode laser.
- the irradiation was performed by a longitudinal incision in the scalp to expose the skull.
- the laser source (wavelength 807 millimicron, 400 mW maximal power output) was attached to the parietal bone in the skull (after exposing the skin) at two points: one between the eyes and one 1 cm posterior to the previous one. The duration of each irradiation was 2 minutes.
- the dispersion of the laser beam after its passage through the skull was measured by an infrared viewer in a preliminary experiment.
- the energy density that reached the brain tissue was 8 mW per square centimeter.
- the other six rats had lasers attached to the skull but the lasers were not connected to an energy source.
- Rats were followed up after surgery for various neurological disorders. All the rats that did not receive laser irradiation showed a prolapsed eyelid on the left side and minor motor neurological deficits at 12 hours post occlusion of the-left carotid artery.
- Occlusion of the left coronary artery was performed on fifteen white mice (25-35 gr.) in a similar method to that described for rats in Experiment I.
- mice Seven of the mice were irradiated with the same laser as in Experiment I. The irradiation was performed through the skin that covers the skull. The power output of the laser was set so that the brain of the mice was exposed to an energy of 5 mW/sq. cm. for 2 minutes.
- mice served as control animals which went through the same process as the laser irradiated mice, but with the laser not turned on.
- mice After induction of the stroke by ligation of the carotid artery, the mice were observed daily for neurological disorders/deficits and loss of weight. The results are presented in Table I.
- the human skull can serve as a “natural lens” that disperses the laser beam so that a larger area of the brain will be laser irradiated.
- the penetration of low energy laser through the human skull is a feasible option to deliver this energy to the brain cells if the external laser source is operated at the proper power output. This energy will cause a beneficial biostimulation on brain cells after stroke and other related disorders.
Abstract
Apparatus for treatment of an ischemic region of brain cells in a cranium, comprising a skull covering adapted to cover at least part of the cranium, at least one guide attached to the skull covering, and a laser source which is operative to direct a laser beam through the at least one guide into the cranium. The at least one guide may include an optic filiter or a waveguide.
Description
- This application is a continuation of U.S. patent application Ser. No. 10/353,130 filed Jan. 28, 2003, which is a continuation of U.S. patent application Ser. No. 09/701,838, filed Apr. 12, 2001, now U.S. Pat. No. 6,537,304, issued Mar. 25, 2003, which is a national phase application under 35 U.S.C. § 371 of International Application No. PCT/IL99/00287 filed May 31, 1999, which claims the benefit of Israeli Patent No. 124722 filed Jun. 2, 1998.
- Cytoprotective effect and increase of survival of neurons in the Central Nervous System (CNS) of mammals following ischemia (as in stroke), by low energy laser (LEL) irradiation.
- Mammalian CNS neurons have a negligible capacity to regenerate following lesion or acute ischemic (no oxygen supply) conditions. A dramatic decrease or complete abolishment of oxygen supply to the nerve cells and other cells in a certain region of the brain can occur due to occlusion of one or more of the arteries that supply blood to the brain (Fisher, M., “Characterizing the Target of Acute Stroke Therapy,” Stroke, Vol. 28, No. 4, pp. 866-872, April 1997). Concomitantly with this event, the neurons of the brain go through a gradual degeneration process that eventually leads to necrosis in the acute ischemic zone. Clinical syndromes such as paraplegia, quadriplegia, etc., are evident due to dysfunction of the nerve cells in the brain.
- The mammalian CNS also has a negligible capacity to regenerate following injury. Limited regeneration of peripheral axons in mammals and CNS in lower vertebrate can take place in a post trauma setting.
- Low energy laser irradiation has recently been found to modulate various processes in different biological systems (Belkin, et al., a critical review of low energy laser bioeffects, Lasers Light Ophthalmology, Vol. 2, p. 63-71, 1988, and Conlan, et al., biostimulation of wound healing by low energy laser irradiation, Journal of Clinical Periodontology, Vol. 23, p. 492-496, 1996). The effect of low energy laser irradiation following trauma has been investigated so far in skin, peripheral nerves and skeletal muscles.
- Assia, et al. (temporal parameters of low energy laser irradiation for optimal delay of post traumatic degeneration of Ito rat optic nerve, Brain Research, 476: 205-212, 1989) described the possibility of delaying the post traumatic process of degeneration and scar tissue formation of a crushed optic never (peripheral nervous system) by low energy laser irradiation.
- U.S. Pat. No. 5,580,555 to Schwartz involves the administration of tumor necrosis factor (TNF) to the sight of injury in the optic nerve in order to facilitate regeneration of axons across the sight of the injury. The use of low energy laser in conjunction with the use of the TNF is suggested to augment the effect of TNF. However, Schwartz presents no experimental results to favor the beneficial effect of the laser. Furthermore, it is described in the detailed description that treatment with TNF alone (without laser irradiation) gives good results.
- It has previously been suggested that regeneration of injured peripheral nerves can-be accelerated by LEL (Rochkind S. Stimulation effect of laser energy on the regeneration of traumatically injured peripheral nerves. The Krim National Medical Inst., Morphogenesis and Regenerations, Vol. 73, pp. 48-50, 1978). .Nissan M. Rochkind S., et al. (HeNe laser irradiation delivered transcutaneously: its effect on sciatic nerve of rats. Laser. Surg. Med., Vol. 6, pp. 435-438, 1986) also demonstrated that transcutaneous LEL of sciatic nerve induced an increase in the amplitude of the electrical signals recorded in the irradiated nerve, i.e., increased the size of the action potential.
- U.S. Pat. No. 4,966,144 to Rochkind, et al., deals with a method of inducing functional regeneration. of nerve fibers of an injured sight. of the. spinal cord (or using grafts of peripheral nerves which were placed into the injured sight) by a light source which generates light at a wavelength of 330-1200 nm. The method involves only the spinal cord but not the brain. Moreover, the method is not related to an acute ischemic phase of nerve cells in the CNS as in a situation of “stroke” nor is the cytoprotective effect of laser irradiation cited in Rochkind, et al.
- It has previously been reported that the low energy laser irradiation causes a decrease in the inflammatory response following injury to skeletal muscles (Bibikova A. & U. Oron. Promotion of muscle regeneration following cold injury to the toad (Bufo Viridis) gastrocnemius muscle by low energy laser irradiation. Anat. Rec. (1993), Vol. 235, pp. 374-380 and N. Weiss & U. Oran Enhancement of muscle regeneration in the rat gastrocnemius muscle by low energy laser irradiation. Anat. Embryol. (1992), Vol. 186, pp. 497-503). The above phenomenon may suggest possible cytoprotective effect of at least the mitochondria and maybe other structures of the cell by the LEL. Thus, LEL irradiation allows cells under stressful conditions of low or no oxygen supply to maintain their viability in spite of the harsh conditions. The irradiated cells most probably do not degenerate to the same extent as the non-irradiated cells and therefore also the inflammatory response, which is typical to tissues undergoing a degenerative process following injury, is markedly decreased. Furthermore, LEL irradiation has been found to enhance the process of formation of new blood vessels (angiogenesis) in injured skeletal muscles (Bibikovu A. Belkin A. and Oron U. Enhancement of angiogenesis in regenerating gastrocnemius muscle of the toad (Butfo Viridis) by low energy laser irradiation. Anat. Embryol (1994), Vol. 190, pp. 597-602.).
- So far, despite significant research efforts for many years worldwide, a safe and effective method of inhibiting or eliminating the adverse irreversible effects of stroke and other ischemic events on brain cells and the significant clinical manifestations of it on animal and human body function has yet to be developed.
- The present invention seeks to provide a novel method and apparatus for using LEL irradiation to protect cells under acute ischemic conditions in the brain. In accordance with the present invention, in the initial phase of ischemia, the LEL irradiation causes an enhanced angiogenesis process which in turn causes a regeneration process in the injured brain cells in the ischemic zone, thereby allowing for greater protection of the cells in the future.
- There is thus provided in accordance with a preferred embodiment of the present invention apparatus for treatment of an. ischemic region of brain cells in a cranium, including a skull covering adapted to cover at least part of a cranium, at least one guide attached to the skull covering, and a laser source which is operative to direct a laser beam through the at least one guide into a cranium. The at least one guide may include an optic fiber or a waveguide.
- In accordance with a preferred embodiment of the present invention, the laser source includes a diode laser.
- Further, in accordance with a preferred embodiment of the present invention, a laser controller is operatively connected to the laser source which controls operation of the laser source.
- Still further in accordance with a preferred embodiment of the present invention, an actuator which is operative to move the laser source further from or closer to a cranium.
- Additionally, in accordance with a preferred embodiment of the present invention, the skull covering includes sealing material at a skull-contacting periphery thereof.
- In accordance with a preferred embodiment of the present invention, a timer is mounted on the skull covering.
- Further in accordance with a preferred embodiment of the present invention, an indicator light is mounted on the skull covering.
- Still further in accordance with a preferred embodiment of the present invention, a plurality of the guides are attached to the skull covering which direct a plurality of the laser beams in a plurality of directions.
- Additionally in accordance with a preferred embodiment of the present invention, a-plurality of the guides are attached to the skull covering which are operative to focus a plurality of the laser beams in a plurality of focal lengths into a cranium.
- In accordance with a preferred embodiment of the present invention, a plurality of the guides is commonly attached to the laser source.
- Further in accordance with a preferred embodiment of the present invention, a plurality of the laser sources and a plurality of the guides are provided, wherein each source directs a laser beam through one the guide.
- The present invention will be understood and appreciated more fully from the following detailed description, taken in conjunction with the drawings in which:
-
FIG. 1 is a simplified pictorial illustration of apparatus for treatment of an ischemic region of brain cells in a cranium, constructed and operative in accordance with a preferred embodiment of the present invention; -
FIG. 2 is a simplified pictorial illustration of apparatus for treatment of an ischemic region of brain cells in a cranium, constructed and operative in accordance with another preferred embodiment of the present invention; and -
FIG. 3 is a simplified pictorial illustration of apparatus for treatment of an ischemic region of brain cells in a cranium, constructed and operative in accordance with yet another preferred embodiment of the present invention. - Reference is now made to
FIG. 1 which illustratesapparatus 10 for treatment of an ischemic region of brain cells in a cranium, in accordance with a preferred embodiment of the present invention. -
Apparatus 10 preferably includes a multiplicity oflaser sources 12, such as diode lasers, arranged for multidirectional multifocal irradiation of the cranium.Laser sources 12 are mounted in a skull covering 14, preferably constructed of metal, plastic or any other irradiation blocking material, and are preferably controlled by alaser controller 15, either mounted externally or internally on skull covering 14. Eachlaser source 12 preferably delivers laser energy to the skull via aguide 16, such as an optic fiber or waveguide.Laser sources 12 are preferably connected to aservo system 18 which includes one ormore actuators 20 which can move laser sources further from or closer to the cranium, thereby controlling the distance of the distal ends ofguides 16 from the cranium. - Skull covering 14 may cover the entire skull including the brainstem, or alternatively, only part of the skull.
Apparatus 10 preferably includes one or more indicator lights 22 which provide various operational visual signals, such as malfunction warning signals, for example. Skull covering 14 preferably has sealingmaterial 24 at its skull-contacting periphery so as to prevent stray radiation from escaping.Apparatus 10 preferably includes atimer 26 with an LCD to allow an operator to monitor the irradiation process in real time. Other safety options may be included. - Reference is now made to
FIG. 2 which illustratesapparatus 30 for treatment of an ischemic region of brain cells in a cranium, in accordance with another preferred embodiment of the present invention.Apparatus 30 is basically the same asapparatus 10, with like numerals designating like elements, although not all elements are shown inFIG. 2 for the sake of simplicity.Apparatus 30 differs fromapparatus 10 in thatapparatus 30 includes onelaser source 12 and a multiplicity ofguides 16 which are arranged for multidirectional multifocal irradiation of the cranium, as described above forapparatus 10. - Reference is now made to
FIG. 3 which illustratesapparatus 40 for treatment of an ischemic region of brain cells in a cranium, in accordance with yet another preferred embodiment of the present invention.Apparatus 40 is basically the same asapparatus FIG. 3 for the sake of simplicity.Apparatus 40 differs fromapparatus apparatus 40 also includes aheartbeat sensor probe 42.Guide 16 may be housed inside or outside ofprobe 42, in accordance with the requirements of the particular application.Apparatus 40 is particularly useful for treating newborn infants, as is now described. - During the process of birth, a newborn may be subject to different kinds of stress-elated problems, one example being insufficient oxygen and blood supply to the brain which is a major cause of morbidity and mortality. Factors contributing to brain damage and other adverse outcomes are complex. Both severe hypoxia-ischemia and prolonged hypoxia of lesser severity may cause brain damage (Low J A, Cerebral perfusion, metabolism and outcome; Curr Opin Pediatr: 7(2): pp. 132-9 April 1995). Many morbid conditions are associated with hypoxia such as hypoxic-ischemic encephalopathy., cerebral palsy, microcephaly, seizure disorders, mental retardation, educational failure and others (Behrman, Kliegman, et al., Nelson's Textbook of Pediatrics, 15th Ed. W. B. Saunders Company: pp. 431-3; 1996).
-
Apparatus 40 is particularly useful for treating newborns, such as during exit from the vagina, whereinlaser sources 12 can deliver laser energy to the: cranium of the newborn infant quickly and efficiently. In such use for newborns,apparatus 40 may be fashioned without skull covering 14, if desired. Alternatively, an assortment ofskull coverings 14 of different sizes and shapes may be provided to a hospital or clinic for perinatal care. Different energy delivery coefficients may be calculated forlaser sources 12 depending upon the particular application. The position of the laser sources and the paths of the laser beams into the cranium are based on various factors, such as an anatomical consideration of the newborn (for example, the anatomy of the fontanels). -
Apparatus 40 can be combined with conventional monitoring systems and with those under current development. The technique of irradiating the brain withapparatus 40 may be used in conjunction with other methods for protecting the brain, such as the use of glutamate receptor antagonists, glucocorticoids, voltage sensitive calcium channel antagonists etc. (Tuor U I, Del Bigio. M R et al., Brain damage due to cerebral hypoxialischemia in. the neonate: pathology and pharmacological modification; Cerebrovasc Brain Metab Rev, 8(2): pp 159-93 Summer 1996). - The invention was carried out using the above-described apparatus in two exemplary experiments which are now described.
- Experiment I:
- The left common carotid artery of 12 mature Sprague-Dawley rats (250-300 gr. body weight anesthetized with Avertin) was exposed by a longitudinal incision to the frontal midline section of the neck. It was then occluded by ligation with a silk (4-0) thread.
- The brains of six rats were irradiated by a diode laser. The irradiation was performed by a longitudinal incision in the scalp to expose the skull. The laser source (wavelength 807 millimicron, 400 mW maximal power output) was attached to the parietal bone in the skull (after exposing the skin) at two points: one between the eyes and one 1 cm posterior to the previous one. The duration of each irradiation was 2 minutes. The dispersion of the laser beam after its passage through the skull was measured by an infrared viewer in a preliminary experiment. The energy density that reached the brain tissue was 8 mW per square centimeter. The other six rats had lasers attached to the skull but the lasers were not connected to an energy source.
- Rats were followed up after surgery for various neurological disorders. All the rats that did not receive laser irradiation showed a prolapsed eyelid on the left side and minor motor neurological deficits at 12 hours post occlusion of the-left carotid artery.
- The-six rats that were irradiated as above revealed the-following:
- One had a prolapsed eyelid on the left side with no other symptoms. All other rats revealed neither eyelid prolapse nor any neurological deficits.
- Experiment II:
- Occlusion of the left coronary artery was performed on fifteen white mice (25-35 gr.) in a similar method to that described for rats in Experiment I.
- Seven of the mice were irradiated with the same laser as in Experiment I. The irradiation was performed through the skin that covers the skull. The power output of the laser was set so that the brain of the mice was exposed to an energy of 5 mW/sq. cm. for 2 minutes.
- Since the laser beam beyond the skull was dispersed to a diameter of approximately 1.5 cm, only one irradiation in the center of the parietal bone was performed. The irradiation covered the entire dorsal part of the brain.
- The other 8 mice served as control animals which went through the same process as the laser irradiated mice, but with the laser not turned on.
- After induction of the stroke by ligation of the carotid artery, the mice were observed daily for neurological disorders/deficits and loss of weight. The results are presented in Table I.
- It can be seen from Table I that neurological deficits such as prolapse of the left eyelid and paresis of hind legs (which was also evident by difficulty in locomotion) was significantly higher in the control non-irradiated mice. Furthermore, in 7 out of the 8 non-irradiated mice examined, the ligation of the left carotid artery resulted in up to 50% loss of weight and eventual death. In none of the laser irradiated mice was there a massive weight loss nor did any of them die due to the ligation of the left carotid artery.
- It is therefore concluded that laser irradiation most probably has a protective effect on the nerve cells of the CNS or some other protective effect on the CNS as a whole unit. This effect inhibited adverse consequences that usually led to death in this experimental model. It may be postulated that the same protective effect may also be beneficial in the case of stroke or other ischemic events in the CNS of humans.
TABLE I Effect of Laser Irradiation on Mice Post Ligation of the Left Common Carotid Artery. Death up to 10 days post Paresis in Prolapse of Significant loss Treatment ligation. hind legs. left eyelid. of weight. Control 7/8 6/8 6/8 7/8 (non irradiated) Laser irradiated 0/7 0/7 1/7 0/7 - In addition to the above experiments, penetration of low energy laser irradiation through a human skull was studied using a fresh human skull. A Ga—As diode laser was applied (800 mW maximal output) and a laser meter was placed in the inner side of the skull cavity in order to detect the energy power and dispersion (using a laser infrared viewer) of the laser after penetration through the skull. The beam diameter of the laser was dispersed from 2 mm externally to the skull to 3.5 cm in the skull cavity after penetration through the skull wall in the parietal region of the skull (a width of about 8 mm). The energy density measured inside the skull cavity was 3 mW/sq.cm. In the squamosal region (side region) of the human skull, the width of the skull is about 5 mm; so it can be expected that penetration of the laser energy should be better.
- The above study shows that the human skull can serve as a “natural lens” that disperses the laser beam so that a larger area of the brain will be laser irradiated. The penetration of low energy laser through the human skull is a feasible option to deliver this energy to the brain cells if the external laser source is operated at the proper power output. This energy will cause a beneficial biostimulation on brain cells after stroke and other related disorders.
- It will be appreciated by persons skilled in the art that the present invention is not limited by what has been particularly shown and described hereinabove. Rather the scope of the present invention includes both combinations and subcombinations of the features described hereinabove as well as modifications and variations thereof which would occur to a person of skill in the art upon reading the foregoing description and which are not in the prior art.
Claims (2)
1. Apparatus for treatment of an ischemic region of brain cells in a cranium, comprising:
a skull covering adapted to cover at least part of a cranium;
at least one guide attached to said skull covering; and
a laser source which is operative to direct a laser beam through said at least one guide into a cranium.
2-13. (canceled)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/127,003 US20050203595A1 (en) | 1998-06-02 | 2005-05-11 | Ischemia laser treatment |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL124722 | 1998-06-02 | ||
IL12472298A IL124722A0 (en) | 1998-06-02 | 1998-06-02 | Ischemia laser treatment |
PCT/IL1999/000287 WO1999062599A1 (en) | 1998-06-02 | 1999-05-31 | Ischemia laser treatment |
US09/701,838 US6537304B1 (en) | 1998-06-02 | 1999-05-31 | Ischemia laser treatment |
US10/353,130 US6918922B2 (en) | 1998-06-02 | 2003-01-28 | Ischemia laser treatment |
US11/127,003 US20050203595A1 (en) | 1998-06-02 | 2005-05-11 | Ischemia laser treatment |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/353,130 Continuation US6918922B2 (en) | 1998-06-02 | 2003-01-28 | Ischemia laser treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
US20050203595A1 true US20050203595A1 (en) | 2005-09-15 |
Family
ID=11071582
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/701,838 Expired - Lifetime US6537304B1 (en) | 1998-06-02 | 1999-05-31 | Ischemia laser treatment |
US10/353,130 Expired - Lifetime US6918922B2 (en) | 1998-06-02 | 2003-01-28 | Ischemia laser treatment |
US11/127,003 Abandoned US20050203595A1 (en) | 1998-06-02 | 2005-05-11 | Ischemia laser treatment |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/701,838 Expired - Lifetime US6537304B1 (en) | 1998-06-02 | 1999-05-31 | Ischemia laser treatment |
US10/353,130 Expired - Lifetime US6918922B2 (en) | 1998-06-02 | 2003-01-28 | Ischemia laser treatment |
Country Status (4)
Country | Link |
---|---|
US (3) | US6537304B1 (en) |
AU (1) | AU4056699A (en) |
IL (1) | IL124722A0 (en) |
WO (1) | WO1999062599A1 (en) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040138727A1 (en) * | 2001-11-01 | 2004-07-15 | Taboada Luis De | Device and method for providing phototheraphy to the brain |
US20040153130A1 (en) * | 2002-05-29 | 2004-08-05 | Amir Oron | Methods for treating muscular dystrophy |
US20060223155A1 (en) * | 2002-11-01 | 2006-10-05 | Jackson Streeter | Enhancement of in vitro culture or vaccine production in bioreactors using electromagnetic energy |
US20080221211A1 (en) * | 2007-02-02 | 2008-09-11 | Jackson Streeter | Method of treatment of neurological injury or cancer by administration of dichloroacetate |
US7848035B2 (en) | 2008-09-18 | 2010-12-07 | Photothera, Inc. | Single-use lens assembly |
US8025687B2 (en) | 2003-01-24 | 2011-09-27 | Photothera, Inc. | Low level light therapy for enhancement of neurologic function |
US20110238138A1 (en) * | 2010-03-26 | 2011-09-29 | Kosaku Takada | Hair growth device |
US8308784B2 (en) | 2006-08-24 | 2012-11-13 | Jackson Streeter | Low level light therapy for enhancement of neurologic function of a patient affected by Parkinson's disease |
RU2495688C1 (en) * | 2012-03-28 | 2013-10-20 | Государственное бюджетное учреждение здравоохранения Центр организации специализированной медицинской помощи "Челябинский государственный институт лазерной хирургии" | Method of treating cerebral ischemia in experiment |
US9993659B2 (en) | 2001-11-01 | 2018-06-12 | Pthera, Llc | Low level light therapy for enhancement of neurologic function by altering axonal transport rate |
US10188872B2 (en) | 2006-01-30 | 2019-01-29 | Pthera LLC | Light-emitting device and method for providing phototherapy to the brain |
US10357662B2 (en) | 2009-02-19 | 2019-07-23 | Pthera LLC | Apparatus and method for irradiating a surface with light |
US10683494B2 (en) | 2001-11-01 | 2020-06-16 | Pthera LLC | Enhanced stem cell therapy and stem cell production through the administration of low level light energy |
US10695577B2 (en) | 2001-12-21 | 2020-06-30 | Photothera, Inc. | Device and method for providing phototherapy to the heart |
US11273319B2 (en) | 2008-03-18 | 2022-03-15 | Pthera LLC | Method and apparatus for irradiating a surface with pulsed light |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL124722A0 (en) | 1998-06-02 | 1999-01-26 | Oron Amir | Ischemia laser treatment |
WO2000035534A1 (en) * | 1998-12-12 | 2000-06-22 | Virulite Limited | Electromagnetic radiation therapy |
DE20115555U1 (en) * | 2001-09-21 | 2002-01-10 | Weber Michael | Device for attaching at least one laser needle to the body of a patient |
US20030109906A1 (en) * | 2001-11-01 | 2003-06-12 | Jackson Streeter | Low level light therapy for the treatment of stroke |
US20040082940A1 (en) * | 2002-10-22 | 2004-04-29 | Michael Black | Dermatological apparatus and method |
US20030144712A1 (en) * | 2001-12-20 | 2003-07-31 | Jackson Streeter, M.D. | Methods for overcoming organ transplant rejection |
US7316922B2 (en) * | 2002-01-09 | 2008-01-08 | Photothera Inc. | Method for preserving organs for transplant |
US20040132002A1 (en) * | 2002-09-17 | 2004-07-08 | Jackson Streeter | Methods for preserving blood |
US20040082074A1 (en) * | 2002-10-11 | 2004-04-29 | Mcgrath Terrence S. | Axial atomic model for determination of elemental particle field structure and energy levels |
US7284987B2 (en) * | 2002-10-11 | 2007-10-23 | Mcgrath Terrence S | Physical quantum model for the atom |
US7344555B2 (en) | 2003-04-07 | 2008-03-18 | The United States Of America As Represented By The Department Of Health And Human Services | Light promotes regeneration and functional recovery after spinal cord injury |
WO2006024038A2 (en) * | 2004-08-27 | 2006-03-02 | Codman & Shurtleff | Light-based implant for treating alzheimer’s disease |
US7722656B1 (en) * | 2005-02-25 | 2010-05-25 | Kim Robin Segal | Device and method for stimulating hair growth |
USRE47266E1 (en) | 2005-03-14 | 2019-03-05 | DePuy Synthes Products, Inc. | Light-based implants for treating Alzheimer's disease |
US7288108B2 (en) * | 2005-03-14 | 2007-10-30 | Codman & Shurtleff, Inc. | Red light implant for treating Parkinson's disease |
US7351253B2 (en) * | 2005-06-16 | 2008-04-01 | Codman & Shurtleff, Inc. | Intranasal red light probe for treating Alzheimer's disease |
US8262713B2 (en) | 2005-09-26 | 2012-09-11 | Depuy Spine, Inc. | Red light implant for treating osteoporosis |
US7465313B2 (en) * | 2005-09-26 | 2008-12-16 | Depuy Spine, Inc. | Red light implant for treating degenerative disc disease |
US8167920B2 (en) * | 2005-10-31 | 2012-05-01 | Codman & Shurtleff, Inc. | Intranasal delivery of compounds that reduce intrancranial pressure |
US7559945B2 (en) | 2006-01-13 | 2009-07-14 | Clarimedix Inc. | Multi-spectral photon therapy device and methods of use |
US10695579B2 (en) | 2006-01-30 | 2020-06-30 | Pthera LLC | Apparatus and method for indicating treatment site locations for phototherapy to the brain |
US20070179570A1 (en) * | 2006-01-30 | 2007-08-02 | Luis De Taboada | Wearable device and method for providing phototherapy to the brain |
US20080033412A1 (en) * | 2006-08-01 | 2008-02-07 | Harry Thomas Whelan | System and method for convergent light therapy having controllable dosimetry |
CN101795634A (en) * | 2007-04-23 | 2010-08-04 | 透皮帽公司 | Phototherapy light cap |
WO2008136958A1 (en) * | 2007-04-30 | 2008-11-13 | Opthera, Inc. | Uva1-led phototherapy device and method |
US8236036B1 (en) | 2007-07-21 | 2012-08-07 | Frost Ricky A | Optical dermatological and medical treatment apparatus having replaceable laser diodes |
US20090054955A1 (en) * | 2007-08-20 | 2009-02-26 | Kopell Brian H | Systems and Methods for Treating Neurological Disorders by Light Stimulation |
US8249696B2 (en) * | 2007-12-19 | 2012-08-21 | Depuy Spine, Inc. | Smart pedicle tool |
US9180308B1 (en) | 2008-01-18 | 2015-11-10 | Ricky A. Frost | Laser device for intracranial illumination via oral or nasal foramina access |
US9320914B2 (en) | 2008-03-03 | 2016-04-26 | DePuy Synthes Products, Inc. | Endoscopic delivery of red/NIR light to the subventricular zone |
EP3431138B1 (en) * | 2008-04-30 | 2024-01-24 | Implantica Patent Ltd. | Brain stimulation |
US20100198316A1 (en) * | 2009-02-04 | 2010-08-05 | Richard Toselli | Intracranial Red Light Treatment Device For Chronic Pain |
US10071261B2 (en) | 2009-05-01 | 2018-09-11 | Wayne State University | Light therapy treatment |
WO2010127249A1 (en) | 2009-05-01 | 2010-11-04 | Wayne State University | Light therapy treatment |
US20110040356A1 (en) | 2009-08-12 | 2011-02-17 | Fredric Schiffer | Methods for Treating Psychiatric Disorders Using Light Energy |
WO2011146777A2 (en) | 2010-05-19 | 2011-11-24 | Photothera, Inc. | Device and method for providing a synergistic combination of phototherapy and a non-light energy modality to the brain |
FR3024355A1 (en) | 2014-07-30 | 2016-02-05 | Jean Tien | EQUIPMENT FOR THE APPLICATION OF ACTIVE ELEMENTS ON THE SKULL OF A PATIENT |
CN107072821B (en) | 2014-09-09 | 2022-07-01 | 卢米希拉公司 | Multi-wavelength phototherapy devices, systems, and methods for non-invasive treatment of damaged or diseased tissue |
US11123366B1 (en) | 2014-12-15 | 2021-09-21 | Children's Hospital Of Orange County | Methods, materials, and systems for treating injuries to the central nervous system using light emitting nanoparticles |
US10569097B2 (en) | 2015-07-28 | 2020-02-25 | Photonmd, Inc. | Systems and methods for phototherapeutic modulation of nitric oxide |
EP3851162A1 (en) | 2015-07-28 | 2021-07-21 | KNOW Bio, LLC | Phototherapy devices for treatment of dermatological disorders of the scalp |
US10350429B2 (en) * | 2016-02-08 | 2019-07-16 | Ricky A. Frost | Laser device for intracranial illumination via oral or nasal foramina access |
US11167148B2 (en) | 2016-02-26 | 2021-11-09 | Cimphoni Life Sciences LLC | Light emitting bone implants |
US10780296B2 (en) | 2017-09-01 | 2020-09-22 | Reni-Zoe Zivin | Transcranial laser therapy for treatment of acute ischemic stroke |
US11147984B2 (en) | 2020-03-19 | 2021-10-19 | Know Bio, Llc | Illumination devices for inducing biological effects |
US11717698B1 (en) | 2020-04-23 | 2023-08-08 | Hugh McGrath, Jr. | Therapy, treatment, and process for photodynamic inactivation of COVID-19 |
US11654294B2 (en) | 2021-03-15 | 2023-05-23 | Know Bio, Llc | Intranasal illumination devices |
Citations (91)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3107608A (en) * | 1962-05-18 | 1963-10-22 | Flynn & Emrich Company | Two position ink roll bearing socket |
US3375755A (en) * | 1965-10-19 | 1968-04-02 | James A. Hunt | Control device for automating sequential machine operation |
US3810367A (en) * | 1970-07-16 | 1974-05-14 | W Peterson | Container for cooling, storage, and shipping of human organ for transplant |
US4315514A (en) * | 1980-05-08 | 1982-02-16 | William Drewes | Method and apparatus for selective cell destruction |
US4343301A (en) * | 1979-10-04 | 1982-08-10 | Robert Indech | Subcutaneous neural stimulation or local tissue destruction |
US4633872A (en) * | 1983-11-08 | 1987-01-06 | Hgm, Incorporated | Laser optical delivery apparatus |
US4669466A (en) * | 1985-01-16 | 1987-06-02 | Lri L.P. | Method and apparatus for analysis and correction of abnormal refractive errors of the eye |
US4798215A (en) * | 1984-03-15 | 1989-01-17 | Bsd Medical Corporation | Hyperthermia apparatus |
US4846196A (en) * | 1986-01-29 | 1989-07-11 | Wiksell Hans O T | Method and device for the hyperthermic treatment of tumors |
US4930504A (en) * | 1987-11-13 | 1990-06-05 | Diamantopoulos Costas A | Device for biostimulation of tissue and method for treatment of tissue |
US4951653A (en) * | 1988-03-02 | 1990-08-28 | Laboratory Equipment, Corp. | Ultrasound brain lesioning system |
US4951482A (en) * | 1988-12-21 | 1990-08-28 | Gilbert Gary L | Hypothermic organ transport apparatus |
US4966144A (en) * | 1987-06-09 | 1990-10-30 | Simeone Rochkind | Method for inducing regeneration of injured nerve fibers |
US5029581A (en) * | 1986-11-19 | 1991-07-09 | Fuji Electric Co., Ltd. | Laser therapeutic apparatus |
US5037374A (en) * | 1989-11-29 | 1991-08-06 | Carol Mark P | Stereotactic-guided radiation therapy system with variable-length compensating collimator |
US5054470A (en) * | 1988-03-02 | 1991-10-08 | Laboratory Equipment, Corp. | Ultrasonic treatment transducer with pressurized acoustic coupling |
US5150704A (en) * | 1986-06-23 | 1992-09-29 | Fuji Electric Co., Ltd. | Laser therapeutic apparatus |
US5259380A (en) * | 1987-11-04 | 1993-11-09 | Amcor Electronics, Ltd. | Light therapy system |
US5267294A (en) * | 1992-04-22 | 1993-11-30 | Hitachi Medical Corporation | Radiotherapy apparatus |
US5282797A (en) * | 1989-05-30 | 1994-02-01 | Cyrus Chess | Method for treating cutaneous vascular lesions |
US5358503A (en) * | 1994-01-25 | 1994-10-25 | Bertwell Dale E | Photo-thermal therapeutic device and method |
US5368555A (en) * | 1992-12-29 | 1994-11-29 | Hepatix, Inc. | Organ support system |
US5401270A (en) * | 1990-12-19 | 1995-03-28 | Carl-Zeiss-Stiftung | Applicator device for laser radiation |
US5441495A (en) * | 1989-08-17 | 1995-08-15 | Life Resonances, Inc. | Electromagnetic treatment therapy for stroke victim |
US5445608A (en) * | 1993-08-16 | 1995-08-29 | James C. Chen | Method and apparatus for providing light-activated therapy |
US5445146A (en) * | 1995-03-31 | 1995-08-29 | Bellinger; Gary J. | Biological tissue stimulation by low level optical energy |
US5464436A (en) * | 1994-04-28 | 1995-11-07 | Lasermedics, Inc. | Method of performing laser therapy |
US5501655A (en) * | 1992-03-31 | 1996-03-26 | Massachusetts Institute Of Technology | Apparatus and method for acoustic heat generation and hyperthermia |
US5511563A (en) * | 1991-06-21 | 1996-04-30 | Diamond; Donald A. | Apparatus and method for treating rheumatoid and psoriatic arthritis |
US5540737A (en) * | 1991-06-26 | 1996-07-30 | Massachusetts Institute Of Technology | Minimally invasive monopole phased array hyperthermia applicators and method for treating breast carcinomas |
US5601526A (en) * | 1991-12-20 | 1997-02-11 | Technomed Medical Systems | Ultrasound therapy apparatus delivering ultrasound waves having thermal and cavitation effects |
US5616140A (en) * | 1994-03-21 | 1997-04-01 | Prescott; Marvin | Method and apparatus for therapeutic laser treatment |
US5621091A (en) * | 1986-07-25 | 1997-04-15 | The Children's Medical Center Corporation | Probes for and nucleic acid encoding the muscular dystrophy protein, dystrophin |
US5622168A (en) * | 1992-11-18 | 1997-04-22 | John L. Essmyer | Conductive hydrogels and physiological electrodes and electrode assemblies therefrom |
US5627870A (en) * | 1993-06-07 | 1997-05-06 | Atea, Societe Atlantique De Techniques Avancees | Device for treating cerebral lesions by gamma radiation, and corresponding treatment apparatus |
US5640978A (en) * | 1991-11-06 | 1997-06-24 | Diolase Corporation | Method for pain relief using low power laser light |
US5643334A (en) * | 1995-02-07 | 1997-07-01 | Esc Medical Systems Ltd. | Method and apparatus for the diagnostic and composite pulsed heating and photodynamic therapy treatment |
US5728090A (en) * | 1995-02-09 | 1998-03-17 | Quantum Devices, Inc. | Apparatus for irradiating living cells |
US5755752A (en) * | 1992-04-24 | 1998-05-26 | Segal; Kim Robin | Diode laser irradiation system for biological tissue stimulation |
US5817008A (en) * | 1996-10-31 | 1998-10-06 | Spacelabs Medical, Inc. | Conformal pulse oximetry sensor and monitor |
US5879376A (en) * | 1995-07-12 | 1999-03-09 | Luxar Corporation | Method and apparatus for dermatology treatment |
US5902741A (en) * | 1986-04-18 | 1999-05-11 | Advanced Tissue Sciences, Inc. | Three-dimensional cartilage cultures |
US5928207A (en) * | 1997-06-30 | 1999-07-27 | The Regents Of The University Of California | Microneedle with isotropically etched tip, and method of fabricating such a device |
US5928945A (en) * | 1996-11-20 | 1999-07-27 | Advanced Tissue Sciences, Inc. | Application of shear flow stress to chondrocytes or chondrocyte stem cells to produce cartilage |
US5954762A (en) * | 1997-09-15 | 1999-09-21 | Di Mino; Alfonso | Computer-controlled servo-mechanism for positioning corona discharge beam applicator |
US5983141A (en) * | 1996-06-27 | 1999-11-09 | Radionics, Inc. | Method and apparatus for altering neural tissue function |
US5989245A (en) * | 1994-03-21 | 1999-11-23 | Prescott; Marvin A. | Method and apparatus for therapeutic laser treatment |
US6042531A (en) * | 1995-06-19 | 2000-03-28 | Holcomb; Robert R. | Electromagnetic therapeutic treatment device and methods of using same |
US6046046A (en) * | 1997-09-23 | 2000-04-04 | Hassanein; Waleed H. | Compositions, methods and devices for maintaining an organ |
US6045575A (en) * | 1997-09-10 | 2000-04-04 | Amt, Inc. | Therapeutic method and internally illuminated garment for the management of disorders treatable by phototherapy |
US6060306A (en) * | 1995-06-07 | 2000-05-09 | Advanced Tissue Sciences, Inc. | Apparatus and method for sterilizing, seeding, culturing, storing, shipping and testing replacement cartilage tissue constructs |
US6063108A (en) * | 1997-01-06 | 2000-05-16 | Salansky; Norman | Method and apparatus for localized low energy photon therapy (LEPT) |
US6107325A (en) * | 1995-01-17 | 2000-08-22 | Qlt Phototherapeutics, Inc. | Green porphyrins as immunomodulators |
US6112110A (en) * | 1997-01-07 | 2000-08-29 | Wilk; Peter J. | Medical treatment system with scanner input |
US6117128A (en) * | 1997-04-30 | 2000-09-12 | Kenton W. Gregory | Energy delivery catheter and method for the use thereof |
US6129748A (en) * | 1996-03-22 | 2000-10-10 | Kamei; Tsutomu | Apparatus for applying pulsed light to the forehead of a user |
US6143878A (en) * | 1994-11-29 | 2000-11-07 | The University Of Queensland | Sox-9 gene and protein and use in the regeneration of bone or cartilage |
US6146410A (en) * | 1995-11-24 | 2000-11-14 | Nagypal; Tibor | Apparatus for the photodynamic treatment of living beings or organs thereof |
US6149679A (en) * | 1997-09-15 | 2000-11-21 | Adm Tronics Ulimited, Inc. | Corona discharge beam treatment of neuro-cerebral disorders |
US6179771B1 (en) * | 1998-04-21 | 2001-01-30 | Siemens Aktiengesellschaft | Coil arrangement for transcranial magnetic stimulation |
US6198958B1 (en) * | 1998-06-11 | 2001-03-06 | Beth Israel Deaconess Medical Center, Inc. | Method and apparatus for monitoring a magnetic resonance image during transcranial magnetic stimulation |
US6210317B1 (en) * | 1998-07-13 | 2001-04-03 | Dean R. Bonlie | Treatment using oriented unidirectional DC magnetic field |
US6214035B1 (en) * | 1999-03-23 | 2001-04-10 | Jackson Streeter | Method for improving cardiac microcirculation |
US6221095B1 (en) * | 1996-11-13 | 2001-04-24 | Meditech International Inc. | Method and apparatus for photon therapy |
US6277974B1 (en) * | 1999-12-14 | 2001-08-21 | Cogent Neuroscience, Inc. | Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death |
US6290713B1 (en) * | 1999-08-24 | 2001-09-18 | Thomas A. Russell | Flexible illuminators for phototherapy |
US20010044623A1 (en) * | 1998-12-21 | 2001-11-22 | Light Sciences Corporation | Use of pegylated photosensitizer conjugated with an antibody for treating abnormal tissue |
US6358272B1 (en) * | 1995-05-16 | 2002-03-19 | Lutz Wilden | Therapy apparatus with laser irradiation device |
US6363285B1 (en) * | 2000-01-21 | 2002-03-26 | Albert C. Wey | Therapeutic sleeping aid device |
US6364907B1 (en) * | 1998-10-09 | 2002-04-02 | Qlt Inc. | Method to prevent xenograft transplant rejection |
US6379295B1 (en) * | 1997-09-26 | 2002-04-30 | Gilson Woo | Treatment of afflictions, ailments and diseases |
US6395016B1 (en) * | 1996-07-28 | 2002-05-28 | Biosense, Inc. | Method of treating a heart using cells irradiated in vitro with biostimulatory irradiation |
US6397107B1 (en) * | 1998-04-27 | 2002-05-28 | Bokwang Co., Ltd. | Apparatus for embolic treatment using high frequency induction heating |
US20020068927A1 (en) * | 2000-06-27 | 2002-06-06 | Prescott Marvin A. | Method and apparatus for myocardial laser treatment |
US6402678B1 (en) * | 2000-07-31 | 2002-06-11 | Neuralieve, Inc. | Means and method for the treatment of migraine headaches |
US20020087205A1 (en) * | 1999-01-15 | 2002-07-04 | Light Sciences Corporation | Transcutaneous photodynamic treatment of targeted cells |
US6421562B1 (en) * | 2000-07-17 | 2002-07-16 | Jesse Ross | Alternative treatment of a nonsurgically treatable intracranial occlusion |
US6443978B1 (en) * | 1998-04-10 | 2002-09-03 | Board Of Trustees Of The University Of Arkansas | Photomatrix device |
US20020123781A1 (en) * | 2001-03-02 | 2002-09-05 | Shanks Steven C. | Therapeutic laser device |
US6471716B1 (en) * | 2000-07-11 | 2002-10-29 | Joseph P. Pecukonis | Low level light therapy method and apparatus with improved wavelength, temperature and voltage control |
US6514220B2 (en) * | 2001-01-25 | 2003-02-04 | Walnut Technologies | Non focussed method of exciting and controlling acoustic fields in animal body parts |
US6537304B1 (en) * | 1998-06-02 | 2003-03-25 | Amir Oron | Ischemia laser treatment |
US6551308B1 (en) * | 1997-09-17 | 2003-04-22 | Laser-Und Medizin-Technologie Gmbh Berlin | Laser therapy assembly for muscular tissue revascularization |
US20030125782A1 (en) * | 2001-11-15 | 2003-07-03 | Jackson Streeter | Methods for the regeneration of bone and cartilage |
US20030144712A1 (en) * | 2001-12-20 | 2003-07-31 | Jackson Streeter, M.D. | Methods for overcoming organ transplant rejection |
US20030167080A1 (en) * | 2002-03-04 | 2003-09-04 | Hart Barry Michael | Joint / tissue inflammation therapy and monitoring device(s) JITMon device |
US20040014199A1 (en) * | 2002-01-09 | 2004-01-22 | Jackson Streeter | Method for preserving organs for transplant |
US20040044384A1 (en) * | 2002-09-03 | 2004-03-04 | Leber Leland C. | Therapeutic method and apparatus |
US20040132002A1 (en) * | 2002-09-17 | 2004-07-08 | Jackson Streeter | Methods for preserving blood |
US20050009161A1 (en) * | 2002-11-01 | 2005-01-13 | Jackson Streeter | Enhancement of in vitro culture or vaccine production using electromagnetic energy treatment |
US20050107851A1 (en) * | 2002-11-01 | 2005-05-19 | Taboada Luis D. | Device and method for providing phototherapy to the brain |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5844784A (en) * | 1981-09-11 | 1983-03-15 | Nippon Sekigaisen Kogyo Kk | Laser device |
IT1171078B (en) * | 1983-07-04 | 1987-06-10 | Adriano Tessiore | ELECTROMECHANICAL IRRADIANT EQUIPMENT, FOR THE TREATMENT OF HAIR LEATHER, AGAINST Baldness |
DE3686621T2 (en) * | 1985-07-31 | 1993-02-25 | Bard Inc C R | INFRARED LASER CATHETER DEVICE. |
IE911318A1 (en) | 1990-04-23 | 1991-10-23 | Yeda Res & Dev | Use of a tumor necrosis factor for facilitating nerve¹regeneration |
JPH0423634A (en) | 1990-05-18 | 1992-01-28 | Mitsubishi Electric Corp | Line error rate monitor device |
GB9208653D0 (en) | 1992-04-22 | 1992-06-10 | Unilever Plc | Cosmetic composition and process for making it |
US6156028A (en) * | 1994-03-21 | 2000-12-05 | Prescott; Marvin A. | Method and apparatus for therapeutic laser treatment of wounds |
US5849585A (en) * | 1995-05-10 | 1998-12-15 | Genetech, Inc. | Isolating and culturing Schwann cells |
JP2002511774A (en) | 1996-07-28 | 2002-04-16 | バイオセンス・インコーポレイテッド | Electromagnetic heart biostimulation |
US6107608A (en) * | 1997-03-24 | 2000-08-22 | Micron Technology, Inc. | Temperature controlled spin chuck |
CA2364501A1 (en) | 1998-02-23 | 1999-08-26 | Philip W. Passy | Therapeutic cluster laser device |
US6663659B2 (en) * | 2000-01-13 | 2003-12-16 | Mcdaniel David H. | Method and apparatus for the photomodulation of living cells |
US6602275B1 (en) * | 2000-09-18 | 2003-08-05 | Jana Sullivan | Device and method for therapeutic treatment of living organisms |
-
1998
- 1998-06-02 IL IL12472298A patent/IL124722A0/en unknown
-
1999
- 1999-05-31 US US09/701,838 patent/US6537304B1/en not_active Expired - Lifetime
- 1999-05-31 AU AU40566/99A patent/AU4056699A/en not_active Abandoned
- 1999-05-31 WO PCT/IL1999/000287 patent/WO1999062599A1/en active Application Filing
-
2003
- 2003-01-28 US US10/353,130 patent/US6918922B2/en not_active Expired - Lifetime
-
2005
- 2005-05-11 US US11/127,003 patent/US20050203595A1/en not_active Abandoned
Patent Citations (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3107608A (en) * | 1962-05-18 | 1963-10-22 | Flynn & Emrich Company | Two position ink roll bearing socket |
US3375755A (en) * | 1965-10-19 | 1968-04-02 | James A. Hunt | Control device for automating sequential machine operation |
US3810367A (en) * | 1970-07-16 | 1974-05-14 | W Peterson | Container for cooling, storage, and shipping of human organ for transplant |
US4343301A (en) * | 1979-10-04 | 1982-08-10 | Robert Indech | Subcutaneous neural stimulation or local tissue destruction |
US4315514A (en) * | 1980-05-08 | 1982-02-16 | William Drewes | Method and apparatus for selective cell destruction |
US4633872A (en) * | 1983-11-08 | 1987-01-06 | Hgm, Incorporated | Laser optical delivery apparatus |
US4798215A (en) * | 1984-03-15 | 1989-01-17 | Bsd Medical Corporation | Hyperthermia apparatus |
US4669466A (en) * | 1985-01-16 | 1987-06-02 | Lri L.P. | Method and apparatus for analysis and correction of abnormal refractive errors of the eye |
US4846196A (en) * | 1986-01-29 | 1989-07-11 | Wiksell Hans O T | Method and device for the hyperthermic treatment of tumors |
US5902741A (en) * | 1986-04-18 | 1999-05-11 | Advanced Tissue Sciences, Inc. | Three-dimensional cartilage cultures |
US5150704A (en) * | 1986-06-23 | 1992-09-29 | Fuji Electric Co., Ltd. | Laser therapeutic apparatus |
US5621091A (en) * | 1986-07-25 | 1997-04-15 | The Children's Medical Center Corporation | Probes for and nucleic acid encoding the muscular dystrophy protein, dystrophin |
US5029581A (en) * | 1986-11-19 | 1991-07-09 | Fuji Electric Co., Ltd. | Laser therapeutic apparatus |
US4966144A (en) * | 1987-06-09 | 1990-10-30 | Simeone Rochkind | Method for inducing regeneration of injured nerve fibers |
US5259380A (en) * | 1987-11-04 | 1993-11-09 | Amcor Electronics, Ltd. | Light therapy system |
US4930504A (en) * | 1987-11-13 | 1990-06-05 | Diamantopoulos Costas A | Device for biostimulation of tissue and method for treatment of tissue |
US4951653A (en) * | 1988-03-02 | 1990-08-28 | Laboratory Equipment, Corp. | Ultrasound brain lesioning system |
US5054470A (en) * | 1988-03-02 | 1991-10-08 | Laboratory Equipment, Corp. | Ultrasonic treatment transducer with pressurized acoustic coupling |
US4951482A (en) * | 1988-12-21 | 1990-08-28 | Gilbert Gary L | Hypothermic organ transport apparatus |
US5282797A (en) * | 1989-05-30 | 1994-02-01 | Cyrus Chess | Method for treating cutaneous vascular lesions |
US5441495A (en) * | 1989-08-17 | 1995-08-15 | Life Resonances, Inc. | Electromagnetic treatment therapy for stroke victim |
US5037374A (en) * | 1989-11-29 | 1991-08-06 | Carol Mark P | Stereotactic-guided radiation therapy system with variable-length compensating collimator |
US5401270A (en) * | 1990-12-19 | 1995-03-28 | Carl-Zeiss-Stiftung | Applicator device for laser radiation |
US5511563A (en) * | 1991-06-21 | 1996-04-30 | Diamond; Donald A. | Apparatus and method for treating rheumatoid and psoriatic arthritis |
US5540737A (en) * | 1991-06-26 | 1996-07-30 | Massachusetts Institute Of Technology | Minimally invasive monopole phased array hyperthermia applicators and method for treating breast carcinomas |
US5640978A (en) * | 1991-11-06 | 1997-06-24 | Diolase Corporation | Method for pain relief using low power laser light |
US5601526A (en) * | 1991-12-20 | 1997-02-11 | Technomed Medical Systems | Ultrasound therapy apparatus delivering ultrasound waves having thermal and cavitation effects |
US5501655A (en) * | 1992-03-31 | 1996-03-26 | Massachusetts Institute Of Technology | Apparatus and method for acoustic heat generation and hyperthermia |
US5267294A (en) * | 1992-04-22 | 1993-11-30 | Hitachi Medical Corporation | Radiotherapy apparatus |
US5755752A (en) * | 1992-04-24 | 1998-05-26 | Segal; Kim Robin | Diode laser irradiation system for biological tissue stimulation |
US6033431A (en) * | 1992-04-24 | 2000-03-07 | Segal; Kim Robin | Diode laser irradiation system for biological tissue stimulation |
US5622168A (en) * | 1992-11-18 | 1997-04-22 | John L. Essmyer | Conductive hydrogels and physiological electrodes and electrode assemblies therefrom |
US5368555A (en) * | 1992-12-29 | 1994-11-29 | Hepatix, Inc. | Organ support system |
US5627870A (en) * | 1993-06-07 | 1997-05-06 | Atea, Societe Atlantique De Techniques Avancees | Device for treating cerebral lesions by gamma radiation, and corresponding treatment apparatus |
US5445608A (en) * | 1993-08-16 | 1995-08-29 | James C. Chen | Method and apparatus for providing light-activated therapy |
US5358503A (en) * | 1994-01-25 | 1994-10-25 | Bertwell Dale E | Photo-thermal therapeutic device and method |
US5989245A (en) * | 1994-03-21 | 1999-11-23 | Prescott; Marvin A. | Method and apparatus for therapeutic laser treatment |
US5616140A (en) * | 1994-03-21 | 1997-04-01 | Prescott; Marvin | Method and apparatus for therapeutic laser treatment |
US5464436A (en) * | 1994-04-28 | 1995-11-07 | Lasermedics, Inc. | Method of performing laser therapy |
US6143878A (en) * | 1994-11-29 | 2000-11-07 | The University Of Queensland | Sox-9 gene and protein and use in the regeneration of bone or cartilage |
US6107325A (en) * | 1995-01-17 | 2000-08-22 | Qlt Phototherapeutics, Inc. | Green porphyrins as immunomodulators |
US5643334A (en) * | 1995-02-07 | 1997-07-01 | Esc Medical Systems Ltd. | Method and apparatus for the diagnostic and composite pulsed heating and photodynamic therapy treatment |
US5728090A (en) * | 1995-02-09 | 1998-03-17 | Quantum Devices, Inc. | Apparatus for irradiating living cells |
US5445146A (en) * | 1995-03-31 | 1995-08-29 | Bellinger; Gary J. | Biological tissue stimulation by low level optical energy |
US6358272B1 (en) * | 1995-05-16 | 2002-03-19 | Lutz Wilden | Therapy apparatus with laser irradiation device |
US6060306A (en) * | 1995-06-07 | 2000-05-09 | Advanced Tissue Sciences, Inc. | Apparatus and method for sterilizing, seeding, culturing, storing, shipping and testing replacement cartilage tissue constructs |
US6042531A (en) * | 1995-06-19 | 2000-03-28 | Holcomb; Robert R. | Electromagnetic therapeutic treatment device and methods of using same |
US5879376A (en) * | 1995-07-12 | 1999-03-09 | Luxar Corporation | Method and apparatus for dermatology treatment |
US6146410A (en) * | 1995-11-24 | 2000-11-14 | Nagypal; Tibor | Apparatus for the photodynamic treatment of living beings or organs thereof |
US6129748A (en) * | 1996-03-22 | 2000-10-10 | Kamei; Tsutomu | Apparatus for applying pulsed light to the forehead of a user |
US5983141A (en) * | 1996-06-27 | 1999-11-09 | Radionics, Inc. | Method and apparatus for altering neural tissue function |
US6395016B1 (en) * | 1996-07-28 | 2002-05-28 | Biosense, Inc. | Method of treating a heart using cells irradiated in vitro with biostimulatory irradiation |
US6443974B1 (en) * | 1996-07-28 | 2002-09-03 | Biosense, Inc. | Electromagnetic cardiac biostimulation |
US5817008A (en) * | 1996-10-31 | 1998-10-06 | Spacelabs Medical, Inc. | Conformal pulse oximetry sensor and monitor |
US6221095B1 (en) * | 1996-11-13 | 2001-04-24 | Meditech International Inc. | Method and apparatus for photon therapy |
US5928945A (en) * | 1996-11-20 | 1999-07-27 | Advanced Tissue Sciences, Inc. | Application of shear flow stress to chondrocytes or chondrocyte stem cells to produce cartilage |
US6063108A (en) * | 1997-01-06 | 2000-05-16 | Salansky; Norman | Method and apparatus for localized low energy photon therapy (LEPT) |
US6112110A (en) * | 1997-01-07 | 2000-08-29 | Wilk; Peter J. | Medical treatment system with scanner input |
US6117128A (en) * | 1997-04-30 | 2000-09-12 | Kenton W. Gregory | Energy delivery catheter and method for the use thereof |
US5928207A (en) * | 1997-06-30 | 1999-07-27 | The Regents Of The University Of California | Microneedle with isotropically etched tip, and method of fabricating such a device |
US6187210B1 (en) * | 1997-06-30 | 2001-02-13 | The Regents Of The University Of California | Epidermal abrasion device with isotropically etched tips, and method of fabricating such a device |
US6045575A (en) * | 1997-09-10 | 2000-04-04 | Amt, Inc. | Therapeutic method and internally illuminated garment for the management of disorders treatable by phototherapy |
US5954762A (en) * | 1997-09-15 | 1999-09-21 | Di Mino; Alfonso | Computer-controlled servo-mechanism for positioning corona discharge beam applicator |
US6149679A (en) * | 1997-09-15 | 2000-11-21 | Adm Tronics Ulimited, Inc. | Corona discharge beam treatment of neuro-cerebral disorders |
US6551308B1 (en) * | 1997-09-17 | 2003-04-22 | Laser-Und Medizin-Technologie Gmbh Berlin | Laser therapy assembly for muscular tissue revascularization |
US6046046A (en) * | 1997-09-23 | 2000-04-04 | Hassanein; Waleed H. | Compositions, methods and devices for maintaining an organ |
US6379295B1 (en) * | 1997-09-26 | 2002-04-30 | Gilson Woo | Treatment of afflictions, ailments and diseases |
US6443978B1 (en) * | 1998-04-10 | 2002-09-03 | Board Of Trustees Of The University Of Arkansas | Photomatrix device |
US6179771B1 (en) * | 1998-04-21 | 2001-01-30 | Siemens Aktiengesellschaft | Coil arrangement for transcranial magnetic stimulation |
US6397107B1 (en) * | 1998-04-27 | 2002-05-28 | Bokwang Co., Ltd. | Apparatus for embolic treatment using high frequency induction heating |
US6537304B1 (en) * | 1998-06-02 | 2003-03-25 | Amir Oron | Ischemia laser treatment |
US6198958B1 (en) * | 1998-06-11 | 2001-03-06 | Beth Israel Deaconess Medical Center, Inc. | Method and apparatus for monitoring a magnetic resonance image during transcranial magnetic stimulation |
US6210317B1 (en) * | 1998-07-13 | 2001-04-03 | Dean R. Bonlie | Treatment using oriented unidirectional DC magnetic field |
US6364907B1 (en) * | 1998-10-09 | 2002-04-02 | Qlt Inc. | Method to prevent xenograft transplant rejection |
US20010044623A1 (en) * | 1998-12-21 | 2001-11-22 | Light Sciences Corporation | Use of pegylated photosensitizer conjugated with an antibody for treating abnormal tissue |
US6344050B1 (en) * | 1998-12-21 | 2002-02-05 | Light Sciences Corporation | Use of pegylated photosensitizer conjugated with an antibody for treating abnormal tissue |
US20020087205A1 (en) * | 1999-01-15 | 2002-07-04 | Light Sciences Corporation | Transcutaneous photodynamic treatment of targeted cells |
US6267780B1 (en) * | 1999-03-23 | 2001-07-31 | Jackson Streeter | Method for treating musculoskeletal injury |
US6312451B1 (en) * | 1999-03-23 | 2001-11-06 | Jackson Streeter | Low level laser therapy apparatus |
US6290714B1 (en) * | 1999-03-23 | 2001-09-18 | Jackson Streeter | Method for treating bone fracture |
US6214035B1 (en) * | 1999-03-23 | 2001-04-10 | Jackson Streeter | Method for improving cardiac microcirculation |
US6273905B1 (en) * | 1999-03-23 | 2001-08-14 | Jackson Streeter | Method for treating spinal cord transection |
US6290713B1 (en) * | 1999-08-24 | 2001-09-18 | Thomas A. Russell | Flexible illuminators for phototherapy |
US6277974B1 (en) * | 1999-12-14 | 2001-08-21 | Cogent Neuroscience, Inc. | Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death |
US6363285B1 (en) * | 2000-01-21 | 2002-03-26 | Albert C. Wey | Therapeutic sleeping aid device |
US20020068927A1 (en) * | 2000-06-27 | 2002-06-06 | Prescott Marvin A. | Method and apparatus for myocardial laser treatment |
US6471716B1 (en) * | 2000-07-11 | 2002-10-29 | Joseph P. Pecukonis | Low level light therapy method and apparatus with improved wavelength, temperature and voltage control |
US6421562B1 (en) * | 2000-07-17 | 2002-07-16 | Jesse Ross | Alternative treatment of a nonsurgically treatable intracranial occlusion |
US6402678B1 (en) * | 2000-07-31 | 2002-06-11 | Neuralieve, Inc. | Means and method for the treatment of migraine headaches |
US6514220B2 (en) * | 2001-01-25 | 2003-02-04 | Walnut Technologies | Non focussed method of exciting and controlling acoustic fields in animal body parts |
US20020123781A1 (en) * | 2001-03-02 | 2002-09-05 | Shanks Steven C. | Therapeutic laser device |
US20030125782A1 (en) * | 2001-11-15 | 2003-07-03 | Jackson Streeter | Methods for the regeneration of bone and cartilage |
US20030144712A1 (en) * | 2001-12-20 | 2003-07-31 | Jackson Streeter, M.D. | Methods for overcoming organ transplant rejection |
US20040014199A1 (en) * | 2002-01-09 | 2004-01-22 | Jackson Streeter | Method for preserving organs for transplant |
US20030167080A1 (en) * | 2002-03-04 | 2003-09-04 | Hart Barry Michael | Joint / tissue inflammation therapy and monitoring device(s) JITMon device |
US20040044384A1 (en) * | 2002-09-03 | 2004-03-04 | Leber Leland C. | Therapeutic method and apparatus |
US20040132002A1 (en) * | 2002-09-17 | 2004-07-08 | Jackson Streeter | Methods for preserving blood |
US20050009161A1 (en) * | 2002-11-01 | 2005-01-13 | Jackson Streeter | Enhancement of in vitro culture or vaccine production using electromagnetic energy treatment |
US20050107851A1 (en) * | 2002-11-01 | 2005-05-19 | Taboada Luis D. | Device and method for providing phototherapy to the brain |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10758743B2 (en) | 2001-11-01 | 2020-09-01 | Pthera LLC | Method for providing phototherapy to the brain |
US9993659B2 (en) | 2001-11-01 | 2018-06-12 | Pthera, Llc | Low level light therapy for enhancement of neurologic function by altering axonal transport rate |
US10683494B2 (en) | 2001-11-01 | 2020-06-16 | Pthera LLC | Enhanced stem cell therapy and stem cell production through the administration of low level light energy |
US20040138727A1 (en) * | 2001-11-01 | 2004-07-15 | Taboada Luis De | Device and method for providing phototheraphy to the brain |
US20100094384A1 (en) * | 2001-11-01 | 2010-04-15 | Luis De Taboada | System and method for providing phototherapy to the brain |
US10913943B2 (en) | 2001-11-01 | 2021-02-09 | Pthera LLC | Enhanced stem cell therapy and stem cell production through the administration of low level light energy |
US10695577B2 (en) | 2001-12-21 | 2020-06-30 | Photothera, Inc. | Device and method for providing phototherapy to the heart |
US20040153130A1 (en) * | 2002-05-29 | 2004-08-05 | Amir Oron | Methods for treating muscular dystrophy |
US20060223155A1 (en) * | 2002-11-01 | 2006-10-05 | Jackson Streeter | Enhancement of in vitro culture or vaccine production in bioreactors using electromagnetic energy |
US7309348B2 (en) * | 2003-01-24 | 2007-12-18 | Photothera, Inc. | Method for treatment of depression |
US8025687B2 (en) | 2003-01-24 | 2011-09-27 | Photothera, Inc. | Low level light therapy for enhancement of neurologic function |
US8167921B2 (en) | 2003-01-24 | 2012-05-01 | Jackson Streeter | Low level light therapy for enhancement of neurologic function |
US9795803B2 (en) | 2003-01-24 | 2017-10-24 | Pthera LLC | Low level light therapy for enhancement of neurologic function |
US20050187595A1 (en) * | 2003-01-24 | 2005-08-25 | Jackson Streeter | Method for treatment of depression |
US11179572B2 (en) | 2006-01-30 | 2021-11-23 | Pthera LLC | Light-emitting device and method for providing phototherapy to the brain |
US10188872B2 (en) | 2006-01-30 | 2019-01-29 | Pthera LLC | Light-emitting device and method for providing phototherapy to the brain |
US8308784B2 (en) | 2006-08-24 | 2012-11-13 | Jackson Streeter | Low level light therapy for enhancement of neurologic function of a patient affected by Parkinson's disease |
US20080221211A1 (en) * | 2007-02-02 | 2008-09-11 | Jackson Streeter | Method of treatment of neurological injury or cancer by administration of dichloroacetate |
US11273319B2 (en) | 2008-03-18 | 2022-03-15 | Pthera LLC | Method and apparatus for irradiating a surface with pulsed light |
US10071259B2 (en) | 2008-09-18 | 2018-09-11 | Pthera, Llc | Optical assembly |
US8149526B2 (en) | 2008-09-18 | 2012-04-03 | Photothera, Inc. | Single use lens assembly |
US7848035B2 (en) | 2008-09-18 | 2010-12-07 | Photothera, Inc. | Single-use lens assembly |
US10357662B2 (en) | 2009-02-19 | 2019-07-23 | Pthera LLC | Apparatus and method for irradiating a surface with light |
US11219782B2 (en) | 2009-02-19 | 2022-01-11 | Pthera LLC | Apparatus and method for irradiating a surface with light |
US20110238138A1 (en) * | 2010-03-26 | 2011-09-29 | Kosaku Takada | Hair growth device |
RU2495688C1 (en) * | 2012-03-28 | 2013-10-20 | Государственное бюджетное учреждение здравоохранения Центр организации специализированной медицинской помощи "Челябинский государственный институт лазерной хирургии" | Method of treating cerebral ischemia in experiment |
Also Published As
Publication number | Publication date |
---|---|
US20030216797A1 (en) | 2003-11-20 |
WO1999062599A1 (en) | 1999-12-09 |
AU4056699A (en) | 1999-12-20 |
US6918922B2 (en) | 2005-07-19 |
US6537304B1 (en) | 2003-03-25 |
IL124722A0 (en) | 1999-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6537304B1 (en) | Ischemia laser treatment | |
Hamblin | Shining light on the head: photobiomodulation for brain disorders | |
Hamblin | Photobiomodulation for traumatic brain injury and stroke | |
Naeser et al. | Potential for transcranial laser or LED therapy to treat stroke, traumatic brain injury, and neurodegenerative disease | |
US9610460B2 (en) | Light therapy treatment | |
US20210252302A1 (en) | Light therapy treatment | |
US9649507B2 (en) | Low level laser therapy for Alzheimer's disease | |
Johnstone et al. | The potential of light therapy in Parkinson's disease | |
Rosner et al. | Dose and temporal parameters in delaying injured optic nerve degeneration by low‐energy laser irradiation | |
Belkin et al. | Evidence for the existence of low-energy laser bioeffects on the nervous system | |
US11724123B2 (en) | Photobiomodulation therapy to treat a degenerative condition of the retina and/or the optic nerve | |
Lim | The potential of treating alzheimer’s disease with intranasal light therapy | |
KR20160039928A (en) | Device for Alopecia-healing using laser | |
Hamblin et al. | Low-level light therapy aids traumatic brain injury | |
Belkin et al. | Ophthalmic effects of low-energy laser irradiation | |
Xunbin et al. | Phototherapy of Neurodegenerative Diseases: Mechanism, Application, and Prospect | |
Magkouti et al. | Quantitative EEG as outcome measure of the therapeutic effects of transcranial pho-tobiomodulation: a systematic review | |
Caldieraro et al. | Transcranial and systemic photobiomodulation for the enhancement of mitochondrial metabolism in depression | |
Zadorozhnyy et al. | Photobiomodulation therapy in ophthalmology | |
Castel et al. | Low energy laser biostimulation: New prospects for medical applications | |
Naser et al. | Transcranial Photobiomodulation (tPBM) Therapy In Brain Disorders | |
Koski | Emerging treatments | |
Schwartz et al. | Low-energy laser irradiation: a possible neuroprotective modality | |
Johnstone | The potential of light therapy in Parkinson’s | |
Hamblin | MA, 02114, USA. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: PHOTOTHERA, INC., CALIFORNIA Free format text: LICENSE AGREEMENT INCLUDING ASSIGNMENT;ASSIGNOR:ORON,URI;REEL/FRAME:018989/0232 Effective date: 20021001 Owner name: ORON,URI, ISRAEL Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ORON, AMIR;REEL/FRAME:018989/0227 Effective date: 20021001 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |